What Is Enfinity Paraxanthine? The Branded Caffeine Metabolite in Ultra, Plopii, and Pre-Workouts
Roon Team

What Is Enfinity Paraxanthine? The Branded Caffeine Metabolite in Ultra, Plopii, and Pre-Workouts
Enfinity paraxanthine is a branded, purified form of caffeine's primary metabolite, the compound your liver produces when you drink coffee. About 80% of an oral caffeine dose converts to paraxanthine in the body (Lelo et al., 1986). The pitch from the company behind it: skip the middleman, take the metabolite directly, and get a faster, cleaner stimulant effect. That pitch is now inside pre-workouts, oral pouches, and standalone capsules from several brands. Whether the science justifies the premium is a different question.
Below: who makes enfinity, how it is regulated, what the published trials actually measured, and which products contain it. For a broader look at the molecule itself, see our explainer on what paraxanthine is.
Key Takeaways
- Enfinity is a trademarked ingredient, not a unique molecule. The active compound is paraxanthine (1,7-dimethylxanthine), which your body already makes from caffeine.
- Ingenious Ingredients self-affirmed GRAS status in November 2021. That is a company determination, not an FDA review or approval.
- The two published human cognition trials were funded by Ingenious Ingredients, with company co-founders listed as co-authors.
- Paraxanthine has a shorter half-life than caffeine (~3.1 vs. ~4.1 hours in one controlled study), but it is not free of stimulant-type cardiovascular effects.
Who Makes Enfinity and Who Distributes It
Enfinity was developed by Ingenious Ingredients (also styled ING2), co-founded by Ralf Jäger, Martin Purpura, and Shawn Wells. Jäger and Purpura also co-own Increnovo LLC, a nutrition research consultancy. This matters later when we look at who funded and authored the clinical trials.
In August 2023, TSI Group announced an exclusive global distribution agreement for enfinity, covering North America, South America, APAC, and the EU.
Enfinity's marketing states the ingredient is "backed by 23 filed patents." That count appears in secondary blog coverage but could not be independently confirmed through a USPTO or Google Patents search. Multiple patent applications assigned to Ingenious Ingredients (later reassigned to PX ING, LLC) do appear in public databases. The accurate framing: the company says it holds multiple patents. Take the specific count as its own claim.
How Enfinity Is Made and Regulated
Enfinity is sold as a purified paraxanthine powder that supplement brands license and add to their formulas. Enfinity's own FAQ states that the ingredient "is manufactured by NNB Nutrition and exclusively distributed by TSI Group Co., Ltd." Ingenious Ingredients, which developed it and self-affirmed its GRAS status in 2021, is not named anywhere on the site today.
Ingenious Ingredients self-affirmed GRAS status for enfinity in November 2021, covering energy beverages, decaffeinated coffee beverages and powders, and nutrition bars at up to 300 mg per serving.
Self-affirmed GRAS means the company convened an expert panel that determined the ingredient is generally recognized as safe. It does not mean the FDA reviewed or endorsed that conclusion. No FDA GRAS Notice number for paraxanthine was located in this research. Self-affirmed GRAS is legal under the Federal Food, Drug, and Cosmetic Act, but it leaves the safety determination with the company and its chosen experts, not the agency.
| Regulatory / Certification Item | Status | What It Means |
|---|---|---|
| Self-affirmed GRAS | November 2021, up to 300 mg/serving | Company-selected expert panel, not FDA-reviewed |
| FDA GRAS Notice | Not filed (as of this writing) | No FDA review on record |
| Informed Ingredient | Certified as of mid-2024 | Tested for banned substances in sport; not an efficacy or safety endorsement |
| Kosher / Halal | Claimed on enfinity website | Compliance certifications for dietary law |
The Informed Ingredient certification, confirmed on enfinity's own site and the Informed Ingredient registry, is a purity screen for banned substances in sport, not an endorsement of safety or effectiveness.
The Science Enfinity Cites
Two human trials form the backbone of enfinity's evidence base. Both deserve a close look, including who paid for them.
Yoo et al., 2021 (PMID 34836235): Double-blind, placebo-controlled, crossover, 13 healthy adults. A single 200 mg dose of paraxanthine improved cognition, short-term memory, and sustained attention versus placebo. Funded by Ingenious Ingredients. Purpura, Jäger, and Wells are co-authors affiliated with or co-owning the company.
Xing et al., 2021 (PMC8708375): Dose-response trial, 50/100/200 mg, 12 healthy volunteers. The 100 mg and 200 mg doses improved some cognition and attention measures. Repeated 7-day dosing showed no apparent habituation. Same Increnovo/ING2 author affiliations.
Both trials ran at Texas A&M's Exercise & Sport Nutrition Lab, which adds academic rigor. But funding, study design involvement, and co-authorship by the ingredient's developers make these industry-funded studies, not independent replication. That is standard for novel ingredients, and worth flagging when "clinically studied" appears in marketing without the relationship disclosed.
No published data on tolerance beyond 7 days exists.
What Products Actually Contain Enfinity
Here are verified products using licensed enfinity paraxanthine, with sourced doses:
| Brand | Product | Format | Enfinity (mg/serving) | Source |
|---|---|---|---|---|
| MuscleTech | EuphoriQ V2 | Pre-workout powder | 300 | PricePlow |
| MuscleTech | Burn iQ (powder) | Thermogenic powder | 150 (per scoop) | PricePlow |
| MuscleTech | Burn iQ (capsules) | Capsules | 100 (per capsule) | Amazon |
| Ultra | Focus Pouches | Oral pouch | 100 | PricePlow |
| Plopii | Focus Nootropic Pouches | Oral pouch | 120 | Amazon |
| Plopii | Focus Pouches 200mg | Oral pouch | 200 | plopii.com |
| Vita Bloom Labs | Enfinity Paraxanthine | Capsule | 200 | Amazon |
Doses range from 100 mg to 300 mg. The November 2021 self-affirmation reported by NutraIngredients covers up to 300 mg per serving. Enfinity's own site states the ingredient is self-affirmed GRAS but publishes no use level. For side-by-side comparisons, see every enfinity product compared. We have also reviewed Ultra pouches (enfinity) reviewed and Plopii pouches (enfinity) reviewed individually.
Enfinity vs. Plain Caffeine: What Is Actually Different
Paraxanthine is not a new stimulant class. It is caffeine's downstream product. Your liver converts roughly 80% of caffeine to paraxanthine via CYP1A2. Skipping that conversion step produces two practical differences:
1. Shorter half-life. Paraxanthine clears faster than caffeine in the same subjects. Lelo et al. (1986) measured paraxanthine's elimination half-life at roughly 3.1 hours versus caffeine's 4.1 hours in the same subjects. (Note: caffeine's half-life in the general population is more commonly cited as 5 to 6 hours; the 4.1-hour figure reflects this specific controlled study.)
2. Less interindividual variability. Caffeine metabolism speed varies enormously by genetics, sex, oral contraceptive use, and smoking status. Paraxanthine skips the bottleneck enzyme, producing a more uniform response across users.
What paraxanthine does not skip: stimulant-type cardiovascular effects. Benowitz et al. (1995) tested oral paraxanthine and caffeine at matched doses (2 and 4 mg/kg, n=12). Both increased diastolic blood pressure, plasma epinephrine, and free fatty acids, with similar magnitude at the higher dose. Enfinity's home page calls the ingredient "Safer than caffeine" and its FAQ promises "clean, steady energy with fewer of the common side effects often linked to caffeine." On blood pressure and catecholamines at matched doses, the pharmacology does not support a difference.
For a full breakdown, see our comparison of caffeine vs paraxanthine compared.
Certifications and Claims Worth Separating
Independently verifiable: Self-affirmed GRAS (documented in trade press, legal under FDA framework). Informed Ingredient certification (listed on the registry). Published human trials (PubMed-indexed, peer-reviewed). Shorter half-life than caffeine (replicated PK data from Lelo et al.).
Company marketing, not independently confirmed: "Caffeine Evolved" (tagline, not a pharmacological classification). The "23 filed patents" count (patent applications exist publicly, but the tally was not verified). Claims of being "cleaner" or "safer" than caffeine (Benowitz data show comparable sympathomimetic effects at matched doses). MuscleTech's energy expenditure claims for Burn iQ are that brand's positioning, not conclusions from enfinity's published cognition trials.
Read paraxanthine safety and dosage in full for a detailed look at what the safety data does and does not cover.
The Honest State of Paraxanthine as an Ingredient
Enfinity paraxanthine is a real molecule backed by real, if limited, human data. The shorter half-life and reduced variability between users are pharmacokinetic facts, not marketing. The cognitive benefits from two small trials are promising but industry-funded and unreplicated independently. And the "safer than caffeine" framing runs into the Benowitz data showing similar cardiovascular effects at matched doses. Weigh the faster clearance (a genuine advantage for sleep timing) against the higher price and thinner evidence base compared to caffeine, which has decades of independent research behind it.
Frequently Asked Questions
What is enfinity paraxanthine?
Enfinity is a branded, purified form of paraxanthine. Its own site says the ingredient is manufactured by NNB Nutrition and exclusively distributed by TSI Group Co., Ltd. Paraxanthine is caffeine's primary metabolite. About 80% of caffeine converts to it in the body. Taking it directly skips the liver's conversion step, producing a faster onset and shorter duration.
Is enfinity FDA approved?
No. No dietary supplement ingredient is "FDA approved" in the way drugs are. Enfinity has self-affirmed GRAS status, meaning a company-selected expert panel determined it is generally recognized as safe. The FDA has not independently reviewed or issued a GRAS Notice number for paraxanthine.
Is enfinity safe?
Published toxicology data and short-term human trials (up to 7 days) have not identified serious adverse effects at doses up to 300 mg. Paraxanthine does produce stimulant-type cardiovascular effects similar to caffeine at matched doses. Long-term safety data beyond 7 days of repeated dosing has not been published. Talk to your clinician if you have a cardiovascular condition or take medications that interact with stimulants.
How does enfinity compare to caffeine?
Paraxanthine has a shorter elimination half-life (~3.1 hours vs. ~4.1 hours for caffeine in one controlled study; caffeine's half-life in the general population is more commonly cited as 5 to 6 hours), less interindividual variability in metabolism, and similar adenosine receptor antagonism. It is not a different class of stimulant. It is the compound caffeine becomes in your body.
What dose of enfinity is in most products?
Current products range from 100 mg (Ultra pouches, MuscleTech Burn iQ capsules) to 300 mg (MuscleTech EuphoriQ V2 pre-workout). The self-affirmed GRAS determination reported by NutraIngredients covers up to 300 mg per serving.
Does enfinity build tolerance?
The 7-day dose-response trial did not observe habituation at 50, 100, or 200 mg. No data exists beyond 7 days. Paraxanthine acts on adenosine receptors, the same system through which caffeine builds tolerance, so caution is reasonable until longer trials are published.
Can I take enfinity with caffeine?
Some products combine the two. The published trials tested paraxanthine alone. Adding enfinity on top of existing caffeine increases your total stimulant load. Adjust accordingly.
Does Roon contain enfinity or paraxanthine?
No. Roon uses a different approach: caffeine paired with L-theanine, methylliberine (Dynamine), and theacrine (TeaCrine) in a zero-nicotine oral pouch. No paraxanthine is in the formula. See Dynamine vs enfinity head to head for a direct comparison.
A Different Way to Extend Caffeine
Enfinity's core argument is that caffeine's metabolite is better than caffeine itself. Roon takes a different position: rather than replacing caffeine, extend what a moderate dose already does.
Roon is a zero-nicotine oral pouch built on caffeine, L-theanine, methylliberine (Dynamine), and theacrine (TeaCrine). Methylliberine is believed to modulate caffeine's clearance, which is one reason the felt window stretches to 6 to 8 hours from a dose of caffeine closer to a small cup of coffee. L-theanine smooths the response. Theacrine does not build tolerance the way caffeine does, though Roon as a whole contains caffeine and should be treated accordingly.
Roon does not contain paraxanthine, and it is not trying to be an enfinity alternative. The design philosophy is different: extend and smooth a known stimulant rather than swap it out for a less-studied metabolite. If that framing fits your use case, tins start at as little as $0.61 per pouch. Stop at least 8 hours before bed.
Related from Roon
- What paraxanthine is
- Caffeine vs paraxanthine compared
- Dynamine vs enfinity head to head
- Every enfinity product compared
Written by Roon Team






